ACTI — Active Biotech AB publ Share News
0.000.00%
Last trade - 00:00- SEK367.52m
- SEK314.32m
Brief: Active Biotech Announces Rights Issue Of About SEK 55 Mln
Brief: Active Biotech Q2 Loss After Tax Widens To SEK 14.3 Mln
Brief: Active Biotech Receives Orphan Drug Designation
Brief: Active Biotech Q1 Loss Widens To SEK 15.7 Million
Brief: Active Biotech AB Publ Reports Qtrly Loss Per Share Of SEK 0,07
Brief: Reg-Active Biotech Enters Into Global Patent License Agreement With Oncode Institute
Brief: Active Biotech Q3 Loss After Tax At SEK 11.2 Mln
Brief: Active Biotech Q2 Operating Loss Falls To SEK 12.6 Mln
Brief: Active Biotech Q1 Operating Loss Flat At SEK 9.7 Mln
Brief: Active Biotech Q4 Operating Loss Narrows To SEK 4.1 Million
Brief: Active Biotech Enters Into Manufacturing Deal With Famar Health Care Services
Brief: Active Biotech Raises SEK 76.2 Million Through Rights Issue
Brief: Active Biotech Receive Milestone Payment From Neotx
Brief: Active Biotech Receives Milestone Payment From Neotx
Brief: Active Biotech Rights Issue To Provide Proceeds Of SEK 76.2 Million
Brief: Active Biotech Q3 Operating Loss Narrows To SEK 8.3 Mln
Brief: Active Biotech Q2 Operating Loss Widens To SEK 10.1 Mln
Brief: Active Biotech Q1 Operating Loss Narrows To SEK 9.7 Million
Brief: Active Biotech Q4 Operating Loss Widens To SEK 11.2 Mln